User:Avocado J/Avocado Pharma: Difference between revisions

Avocado Pharma
Company type	Public
Industry	Biopharmaceutical; Pharmaceutical industry
Founded	2030; 6 years' time
Founder	A. D. Gunathilake ; C. B. Nugara
Headquarters	Miami, Florida, Florida, United States
Area served	Worldwide; (180+ countries)
Key people	C. B. Nugara; (Chairwoman); A. D. Gunathilake; (CEO)
Products	See list of Avocado Pharma products
Revenue	US$1.059 billion (2032)
Operating income	US$482.059 million (2032)
Net income	US$58.88 million (2032)
Total assets	US$1.321 billion (2032)
Total equity	US$292.102 million (2032)
Number of employees	1,023 (2032)
Parent	Nugara Inc,.
Website	avocado.com

Content deleted Content added

Inline

Revision as of 13:58, 1 September 2020

Avocado Pharma is an American publicly traded biopharmaceutical company founded in 2030. It originated as a spin-off of MMG Laboratories.

@@ Line 12: / Line 12: @@
 | predecessor =
 | foundation = {{start date and age|2030}}
-| founder = M. M. Gunathilake
+| founder = A. D. Gunathilake <br> C. B. Nugara
 | defunct =
 | location = [[Miami, Florida]], [[Florida]], [[United States]]
 | area_served = Worldwide<br><small>(180+ countries)</small>
-| key_people = M. M. Gunathilake<br>{{small|([[President]])}}<br>A. D. Gunathilake<br>{{small|([[CEO]])}}<br>C. B. Nugarae<br>{{small|([[Chairman]])}}
+| key_people = C. B. Nugara<br>{{small|([[Chairman|Chairwoman]])}}<br>A. D. Gunathilake<br>{{small|([[CEO]])}}
 | products = [[Avocado Pharma#Products|See list of Avocado Pharma products]]
 | production =